New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination
2024
New Skin Condition After COVID-19 Vaccine
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Muftah Amira, Lee Stephen, Abbas Mariam
Primary Institution: University of Calgary, University of Saskatchewan
Hypothesis
Can COVID-19 vaccination trigger new-onset cutaneous lichen planus?
Conclusion
The case report suggests a possible link between the Vaxzevria COVID-19 vaccine and the development of cutaneous lichen planus.
Supporting Evidence
- The patient developed lichen planus 8-10 days after receiving the vaccine.
- Multiple treatments were attempted with limited success.
- Partial improvement was observed with narrow-band UVB phototherapy.
Takeaway
A man developed a skin condition called lichen planus after getting a COVID-19 vaccine, and some treatments helped a little.
Methodology
The case report details the patient's medical history, symptoms, treatments, and biopsy results.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
56-year-old male with a history of hypertension and dyslipidemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website